- Home
- NEN vs SGHT Comparison
NEN vs SGHT Comparison
Compare NEN & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- SGHT
- Stock Information
- Founded
- NEN 1977
- SGHT 2011
- Country
- NEN United States
- SGHT United States
- Employees
- NEN N/A
- SGHT N/A
- Industry
- NEN Building operators
- SGHT Medical Specialities
- Sector
- NEN Real Estate
- SGHT Health Care
- Exchange
- NEN Nasdaq
- SGHT Nasdaq
- Market Cap
- NEN 262.4M
- SGHT 222.3M
- IPO Year
- NEN N/A
- SGHT 2021
- Fundamental
- Price
- NEN $73.02
- SGHT $3.44
- Analyst Decision
- NEN
- SGHT Buy
- Analyst Count
- NEN 0
- SGHT 8
- Target Price
- NEN N/A
- SGHT $4.01
- AVG Volume (30 Days)
- NEN 594.0
- SGHT 162.1K
- Earning Date
- NEN 01-01-0001
- SGHT 07-31-2025
- Dividend Yield
- NEN 6.49%
- SGHT N/A
- EPS Growth
- NEN 58.97
- SGHT N/A
- EPS
- NEN 4.56
- SGHT N/A
- Revenue
- NEN $82,531,485.00
- SGHT $78,109,000.00
- Revenue This Year
- NEN N/A
- SGHT N/A
- Revenue Next Year
- NEN N/A
- SGHT $11.60
- P/E Ratio
- NEN $16.22
- SGHT N/A
- Revenue Growth
- NEN 6.12
- SGHT N/A
- 52 Week Low
- NEN $68.98
- SGHT $2.03
- 52 Week High
- NEN $84.00
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- NEN 47.71
- SGHT 37.27
- Support Level
- NEN $73.00
- SGHT $3.36
- Resistance Level
- NEN $73.25
- SGHT $4.33
- Average True Range (ATR)
- NEN 0.22
- SGHT 0.26
- MACD
- NEN 0.16
- SGHT -0.13
- Stochastic Oscillator
- NEN 67.11
- SGHT 6.39
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.